Skip to main content
Caplight Logo









Okava Pharmaceuticals

Okava Pharmaceuticals

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://okava.com/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Okava Pharmaceuticals is a biotechnology company that develops pet-specific therapeutics and drug-delivery systems to extend the healthy lifespan of dogs and cats.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

veterinary biotechnologypet therapeuticsdrug repurposingveterinary drug deliverycompanion animal healthpet pharmamodified-release medicationclinical-stage biotechveterinary medicinetranslational medicinedrug out-licensingpet longevityveterinary R&Danimal health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Okava Pharmaceuticals Comparables

Compare Okava Pharmaceuticals with similar companies based on industry and business-model similarity.

Okava Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anivive Lifesciences
83%
Vetbiolix
82%
Vetmab Biosciences
79%

Okava Pharmaceuticals Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Michael Klotsman

Founder & CEO

Founding Team

Okava Pharmaceuticals Investors

Notable investors and investment history

Okava Pharmaceuticals investors
InvestorRounds
Propel(x)Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 103% MoM, reaching 2.2K.

Recent news

Latest coverage and updates

  • is_developingJul 19, 2026

    Okava Pharmaceuticals, Inc. is developing GLP-1 weight-loss drugs on Jul 20th '26.

  • is_developingJul 19, 2026

    Okavapharma is developing anti-obesity treatments for cats on Jul 19th '26.

Okava Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Okava Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Okava Pharmaceuticals's valuation, stock price, and market status.

Is Okava Pharmaceuticals a public or private company?

Okava Pharmaceuticals is a private company.

What is the current stock price of Okava Pharmaceuticals?

Okava Pharmaceuticals is a private company with no public stock price. Caplight tracks Okava Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Okava Pharmaceuticals worth (valuation)?

Valuation information for Okava Pharmaceuticals is not publicly available.

Can I buy Okava Pharmaceuticals stock?

Okava Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Okava Pharmaceuticals's last funding round?

Funding round information for Okava Pharmaceuticals is not publicly available.

Who are the main investors in Okava Pharmaceuticals?

Key investors in Okava Pharmaceuticals include Propel(x).

Will Okava Pharmaceuticals IPO soon?

No public IPO plans have been announced for Okava Pharmaceuticals.

How can I track Okava Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Okava Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range4
Year Founded2015
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?